Navigation Links
Young, unvaccinated adults account for severest flu cases
Date:2/10/2014

of those were immune compromised, chronically ill, or were on a medication that weakened the vaccine's protection.

The study also echoes other studies that have highlighted problems with a rapid test for influenza. Wolfe said 22 of the patients treated at Duke University Hospital had been given a rapid influenza test that came up negative for flu, but they were actually positive when tested by other methods. As a result, they had not received anti-viral medications that might have eased flu symptoms had they been taken early.

"Together, our observations during this influenza season support a high prevalence of the H1N1 virus affecting young adults and requiring ICU care, high false negative rates of rapid flu tests, and delay in starting antiviral treatment," Wolfe said. "Added to the finding of very low vaccination rates among both hospitalized and ICU admissions, our observations support previous findings that vaccination reduces the severity of disease and vaccinations should be encouraged as recommended by the U.S. Centers for Disease Control and Prevention."


'/>"/>

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Perception of fertility affects quality of life in young, female cancer survivors
2. Thousands of unvaccinated adults die each year from preventable diseases
3. Nutritional supplement improves cognitive performance in older adults, study finds
4. Caring for animals may correlate with positive traits in young adults
5. T cell immunotherapy: Promising results in children and adults with leukemia
6. LSUHSC research finds inflammation linked to obesity in adults may be protective in young children
7. Natura Therapeutics product shown to improve decision making skills in older adults
8. Young adults with autism found to have difficulty transitioning into employment
9. Traffic pollution and wood smoke increases asthma in adults
10. Grape consumption associated with healthier eating patterns in US children and adults
11. Despite health benefits, most children and adults have a nutrition gap in omega-3 fatty acids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... promotional pricing and making the Wocket generally available for $229 ... Head of Marketing said, "We,ve extended the opportunity to take ... May. To get your wocket at this special price, submit ... on June 1, you,ll receive a unique code that gives ...
(Date:5/20/2015)... 2015 Research ... the addition of the  "5-year Opportunity ... Market"  report to their offering.  ,     ... analyses trends in the iris recognition ... sectors, globally. Despite hardware pricing and ...
(Date:5/19/2015)... DUBLIN , May 19, 2015 /PRNewswire/ ... ) has announced the addition of the  ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A ... provides an in-depth analysis of the current ... introduction of gene-based tests, their working principles ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... at land-grant universities are a major source of ... industry. To prepare future employees for work in ... in nursery management and production, but availability of ... horticulture programs have contributed to a reduction in ...
... 2011 Dr. Daniel Von Hoff was presented this month ... in sequencing, or spelling out, the DNA of patients with ... advances the art of using the fully sequenced genomes of ... DNA, to help determine the best course of treatment. ...
... Mich. (March 17, 2011) In a ... so-called "orphan" nuclear receptor TR4, Van Andel Research Institute ... more direct role than was previously known in certain ... of the central nervous system. Scientists had previously ...
Cached Biology News:Integrating instructional multimedia in nursery management, production courses 2Dr. Daniel Von Hoff presented with top genomics award from Scripps 2Study indicates vitamin A plays key role in the human body 2
(Date:6/1/2015)... MONTREAL and YONGIN, South Korea ... with great pride that Green Cross Biotherapeutics Inc. (GCBT) ... will be located on the Montreal Technoparc,s Saint-Laurent Campus. ... green field investment projects in Canada ... construction of the first intravenous immunoglobulin (IVIG) and albumin ...
(Date:6/1/2015)... 2015  Novartis is highlighting data from an ... investigational chimeric antigen receptor (CAR) T cell therapy, ... specific types of hard-to-treat non-Hodgkin lymphoma. Findings from ... Pennsylvania,s Perelman School of Medicine (Penn) in adults ... lymphoma (DLBCL) and follicular lymphoma (FL) found an ...
(Date:6/1/2015)... , June 1, 2015  Fennec Pharmaceuticals, ... of positive interim results from a poster presented ... open label randomised phase III trial of the ... in patients receiving cisplatin (Cis) monotherapy for standard ... the American Society of Clinical Oncology (ASCO) 2015 ...
(Date:6/1/2015)... 2015 /CNW/ - Resverlogix Corp. (TSX: RVX) (the "Company") ... at the ERA-EDTA Congress in London, England ... a First-in-Class Epigenetic BET-Inhibitor, on Key Renal Parameters in ... Disease (CKD); a Post-hoc Analysis of Patients from the ... Dr. Kam Kalantar-Zadeh , Professor and Chief, Division ...
Breaking Biology Technology:Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 2Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 4Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 2Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 3Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) 4
... Aug. 4 OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), ... clinical trials announced today that the company has acquired the ... Ltd. The acquisition will be operated by OmniComm,s UK subsidiary, ... exceptional software is used to collect clinical trial data gathered ...
... molecule-sized pores are one step closer to replacing the ... of academic researchers is reporting. Writing this week ... membranes, ability to separate molecules in a mixture is ... processing (RTP). By heating the membranes from room temperature ...
... , , SAN FRANCISCO, Aug. ... positive drug sales/earnings and partnering and M&A deals. As a result, ... 6.5 percent, mirroring the Dow and Nasdaq, which closed the month ... for a July in years. , , Helping ...
Cached Biology Technology:OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd. 2OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd. 3Rapid heating prepares energy-saving zeolite for greater role in industrial separations 2Rapid heating prepares energy-saving zeolite for greater role in industrial separations 3Rapid heating prepares energy-saving zeolite for greater role in industrial separations 4Biotech Hot in July Driven by Positive Drug Data and Acquisitions 2Biotech Hot in July Driven by Positive Drug Data and Acquisitions 3Biotech Hot in July Driven by Positive Drug Data and Acquisitions 4Biotech Hot in July Driven by Positive Drug Data and Acquisitions 5
Mouse monoclonal antibody raised against a partial recombinant FBXO24. NCBI Entrez Gene ID = FBXO24...
Mouse monoclonal antibody raised against a partial recombinant CALCOCO2. NCBI Entrez Gene ID = CALCOCO2...
Mouse monoclonal to Casein Kinase 2 beta ( Abpromise for all tested applications). entrezGeneID: 1460 SwissProtID: P13862...
...
Biology Products: